- Home
- DOMH vs SERA Comparison
DOMH vs SERA Comparison
Compare DOMH & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- SERA
- Stock Information
- Founded
- DOMH 1967
- SERA 2008
- Country
- DOMH United States
- SERA United States
- Employees
- DOMH N/A
- SERA N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- SERA Precision Instruments
- Sector
- DOMH Health Care
- SERA Health Care
- Exchange
- DOMH Nasdaq
- SERA Nasdaq
- Market Cap
- DOMH 94.0M
- SERA 90.6M
- IPO Year
- DOMH N/A
- SERA 2021
- Fundamental
- Price
- DOMH $6.65
- SERA $3.12
- Analyst Decision
- DOMH
- SERA
- Analyst Count
- DOMH 0
- SERA 0
- Target Price
- DOMH N/A
- SERA N/A
- AVG Volume (30 Days)
- DOMH 363.2K
- SERA 108.9K
- Earning Date
- DOMH 11-07-2025
- SERA 11-05-2025
- Dividend Yield
- DOMH 8.10%
- SERA N/A
- EPS Growth
- DOMH N/A
- SERA N/A
- EPS
- DOMH N/A
- SERA N/A
- Revenue
- DOMH $52,811,000.00
- SERA $108,000.00
- Revenue This Year
- DOMH N/A
- SERA $257.66
- Revenue Next Year
- DOMH N/A
- SERA $435.22
- P/E Ratio
- DOMH N/A
- SERA N/A
- Revenue Growth
- DOMH 455.38
- SERA 0.94
- 52 Week Low
- DOMH $0.83
- SERA $1.37
- 52 Week High
- DOMH $13.58
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- DOMH 58.05
- SERA 57.41
- Support Level
- DOMH $5.61
- SERA $2.97
- Resistance Level
- DOMH $6.60
- SERA $3.57
- Average True Range (ATR)
- DOMH 0.46
- SERA 0.34
- MACD
- DOMH 0.02
- SERA 0.03
- Stochastic Oscillator
- DOMH 70.22
- SERA 66.79
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.